Clovis to report third-quarter results Nov. 6
BOULDER —- Clovis Oncology, Inc. (Nasdaq: CLVS) will announce its third quarter 2014 financial results on Thursday, Nov. 6, after the close of the U.S. financial markets.
Clovis’ senior management will host a conference call and live audio webcast at 2:30 p.m. that day to discuss the company’s results in greater detail.
The conference call is being webcast and can be accessed from the Clovis’ website at www.clovisoncology.com. A replay of the webcast will be available for 30 days.
SPONSORED CONTENT
Commercial Solar is a big investment, but not an overwhelming one
Solar offers a significant economic benefit for commercial property owners while also positively impacting the environment and offering a path to compliance for new municipal requirements like Energize Denver. A local, experienced solar installer will help you navigate the complexities of commercial solar to achieve financial success for your project.
Boulder-based Clovis Oncology is a biopharmaceutical company that focuses on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and additional international markets.
BOULDER —- Clovis Oncology, Inc. (Nasdaq: CLVS) will announce its third quarter 2014 financial results on Thursday, Nov. 6, after the close of the U.S. financial markets.
Clovis’ senior management will host a conference call and live audio webcast at 2:30 p.m. that day to discuss the company’s results in greater detail.
The conference call is being webcast and can be accessed from the Clovis’ website at www.clovisoncology.com. A replay of the webcast will be available for 30 days.
Boulder-based Clovis Oncology is a biopharmaceutical company that focuses on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and additional international…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!